Financial Performance - The company's operating revenue for Q1 2023 was ¥193,084,860.79, representing an increase of 185.44% compared to the same period last year[4]. - The net profit attributable to shareholders was -¥28,156,102.73, with a decrease in losses attributed to increased operating revenue and improved gross margin[8]. - The company reported a net loss of CNY 279.36 million for the first quarter of 2023, compared to a net loss of CNY 251.20 million in the same period of the previous year[16]. - Net profit for Q1 2023 was a loss of ¥28,156,102.73, compared to a loss of ¥43,765,110.60 in Q1 2022, showing an improvement of approximately 35.8%[19]. - The company reported a total comprehensive loss of ¥29,186,567.45 for Q1 2023, compared to a loss of ¥44,030,312.98 in Q1 2022, indicating an improvement of approximately 33.6%[20]. - The total comprehensive income for Q1 2023 was -14,143,336.38 RMB, an improvement from -43,053,373.54 RMB in Q1 2022[30]. Cash Flow - The net cash flow from operating activities was -¥58,287,032.14, indicating ongoing cash flow challenges[4]. - Cash inflow from operating activities in Q1 2023 totaled ¥274,471,887.97, compared to ¥120,367,236.33 in Q1 2022, marking an increase of about 128.5%[21]. - Cash outflow from operating activities for Q1 2023 was ¥332,758,920.11, compared to ¥189,867,818.60 in Q1 2022, resulting in a net cash outflow of ¥58,287,032.14[22]. - In Q1 2023, the company reported a net cash flow from operating activities of -36,324,966.05 RMB, an improvement from -81,714,834.55 RMB in Q1 2022, indicating a 55.5% reduction in losses[31]. - The company recorded a net cash inflow from investment activities of 402,894,915.92 RMB in Q1 2023, contrasting with a net outflow of -194,942,857.63 RMB in Q1 2022[32]. - The company experienced a net increase in cash and cash equivalents of 366,569,949.87 RMB in Q1 2023, compared to a significant increase of 2,926,778,796.75 RMB in Q1 2022[32]. Research and Development - R&D investment totaled ¥38,783,368.56, marking a 101.11% increase, driven by enhanced focus on product innovation and technology investment[8]. - The proportion of R&D investment to operating revenue was 20.09%, a decrease of 8.42 percentage points year-on-year[4]. - Research and development expenses for Q1 2023 amounted to ¥38,783,368.56, up from ¥19,284,785.50 in Q1 2022, indicating an increase of approximately 100.0%[18]. - The company's R&D expenses for Q1 2023 were ¥38,783,368.56, up from ¥19,284,785.50 in Q1 2022, reflecting an increase of about 100.3%[27]. Assets and Liabilities - Total assets at the end of the reporting period were ¥5,767,413,926.82, a decrease of 1.68% from the end of the previous year[5]. - The company's total assets amounted to approximately CNY 5.77 billion, a decrease from CNY 5.87 billion as of December 31, 2022, representing a decline of about 1.2%[16]. - The company's total non-current assets rose to CNY 2.82 billion from CNY 2.55 billion, indicating an increase of approximately 10.6%[15]. - The company's total liabilities decreased to CNY 545.48 million from CNY 614.61 million, a reduction of about 11.3%[16]. - The total current liabilities decreased to CNY 233.33 million from CNY 312.96 million, reflecting a reduction of about 25.4%[16]. - The total liabilities as of March 31, 2023, were ¥359,602,916.10, down from ¥388,508,447.91 at the end of 2022, indicating a reduction of approximately 7.4%[26]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,040, with the largest shareholder holding 30.09% of the shares[9]. - The company's total equity attributable to shareholders decreased to CNY 5.22 billion from CNY 5.25 billion, a decline of about 0.6%[16]. - The company's total equity as of March 31, 2023, was ¥5,277,118,875.53, down from ¥5,293,756,856.10 at the end of 2022, reflecting a decrease of approximately 0.3%[26]. Inventory and Receivables - The company's inventory as of March 31, 2023, was CNY 513.78 million, slightly down from CNY 533.28 million, a decrease of about 3.7%[14]. - The company's accounts receivable increased to CNY 161.66 million from CNY 138.00 million, representing an increase of approximately 17.2%[14]. - The company reported a decrease in accounts payable from ¥98,937,077.88 in 2022 to ¥66,759,570.85 in Q1 2023, indicating a reduction of about 32.5%[25]. Other Income - The company reported non-recurring gains of ¥17,409,834.26, primarily from government subsidies and other non-operating income[7]. - Other income for Q1 2023 was ¥7,942,569.64, compared to ¥5,513,458.00 in Q1 2022, representing an increase of about 43.9%[18].
天岳先进(688234) - 2023 Q1 - 季度财报